AHR and chronic myelogenous leukemia, BCR-ABL1 positive: As shown in Fig 2A, there was a significant reduction of AHR mRNA expression in CML patients at diagnosis as compared to healthy controls (n = 15) and this difference was highly significant (Fig 2A).